Showing results (621-630 of 652) with videos related to

Sort By:
Pageof 66
Neuropsychopharmacology Reports|September 11, 2025
Amelioration of Adults' Mental Health Conditions and Symptoms Through Spiritual Energy Therapy: Randomized Controlled TrialMahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, et al.
Neuropsychopharmacology Reports|September 10, 2025
Concerns Regarding Masataka et al.'s "Revisiting the Gateway Drug Hypothesis for Cannabis: A Secondary Analysis of a Nationwide Survey Among Community Users in Japan"Zui C Narita
Neuropsychopharmacology Reports|February 8, 2023
Characteristic association of symbol coding test score with occupational function in Japanese patients with schizophreniaYukako Watanabe, Sho Kanata, Motomu Suga, et al.
Neuropsychopharmacology Reports|February 11, 2026
In Response to "Concerns Regarding Masataka et al.'s 'Revisiting the Gateway Drug Hypothesis for Cannabis'"Yuji Masataka, Toshihiko Matsumoto
Neuropsychopharmacology Reports|June 26, 2025
Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta-AnalysisYasufumi Nishii, Kenji Sakuma, Shun Hamanaka, et al.
Neuropsychopharmacology Reports|June 14, 2025
Prevalence of Over-the-Counter Drug Abuse and Associated Psychosocial Factors Among High School Students: A Nationwide Cross-Sectional Survey in JapanTakuya Shimane, Satoshi Inoura, Maki Kitamura, et al.
Neuropsychopharmacology Reports|April 21, 2025
Functional Diversity of Serotonin Neurons in the Dorsal and Median Raphe Nuclei in Emotional ResponsesYu Ohmura, Kazuki Nagayasu
Neuropsychopharmacology Reports|February 28, 2026
Persistent Interleukin-1β Elevation in Post-COVID-19 Patients: Findings From a Nationwide Registry Study in JapanNaoki Takamatsu, Hiroki Kimura, Mari S Oba, et al.
Neuropsychopharmacology Reports|March 3, 2026
Increased Cerebrospinal Fluid Lactate Levels in Schizophrenia and Major Depressive Disorder: NCNP Biobank Study in JapanHideo Hagihara, Kotaro Hattori, Hiroshi Kunugi, et al.
Neuropsychopharmacology Reports|March 2, 2026
Eight-Year Progression of Clinical Practice Implementation Following Guideline Training in the EGUIDE ProjectKenta Ide, Kazuhiko Yamamuro, Hisashi Yamada, et al.
Pageof 66